Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators and their colleagues.
CDC backs GSK and Pfizer vaccines to bring RSV protection one step closer – Pharmaceutical Technology
The final decision on whether patients will be able to access GSK and Pfizer’s vaccines before the upcoming RSV season now lies with the CDC.
June 22, 2023